| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 302.25M | 325.23M | 375.16M | 385.47M | 387.39M |
| Gross Profit | 60.83M | 28.63M | 45.75M | 79.84M | 34.93M |
| EBITDA | 89.24M | 61.14M | -77.26M | -34.46M | 58.78M |
| Net Income | -98.12M | -322.05M | -230.66M | -340.41M | 22.59M |
Balance Sheet | |||||
| Total Assets | 1.18B | 1.30B | 1.63B | 1.89B | 2.27B |
| Cash, Cash Equivalents and Short-Term Investments | 40.51M | 56.41M | 45.85M | 35.07M | 44.93M |
| Total Debt | 312.49M | 401.97M | 369.77M | 422.73M | 536.48M |
| Total Liabilities | 954.90M | 995.73M | 1.02B | 1.05B | 1.11B |
| Stockholders Equity | 28.85M | 126.96M | 449.01M | 679.67M | 1.02B |
Cash Flow | |||||
| Free Cash Flow | 43.72M | 96.33M | 88.00M | 101.43M | 67.89M |
| Operating Cash Flow | 47.08M | 97.46M | 88.73M | 104.28M | 116.23M |
| Investing Cash Flow | -2.96M | -968.00K | -43.00K | -2.61M | -27.43M |
| Financing Cash Flow | -52.49M | -80.13M | -91.25M | -98.68M | -86.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$1.85B | 4.14 | 16.17% | 12.15% | -3.66% | 4.32% | |
73 Outperform | HK$1.09B | 17.86 | 5.24% | 13.24% | -13.83% | 50.41% | |
66 Neutral | HK$38.93B | 4.34 | 11.37% | 6.69% | -5.48% | -4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | HK$1.80B | 5.34 | 1.40% | 3.23% | -10.56% | -29.26% | |
46 Neutral | HK$180.67M | 7.08 | 3.16% | 2.02% | -5.91% | -45.90% | |
45 Neutral | HK$105.27M | -0.93 | -145.87% | ― | -7.01% | 69.39% |